Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems
Jan Schjøtt,1–3 Jenny Bergman3 1Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, 2Institute of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, 3Regional Medicines Information and Pharmacovigilance C...
Main Authors: | Schjøtt J, Bergman J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/joint-medicine-information-and-pharmacovigilance-services-could-improv-a17428 |
Similar Items
-
Big data, medicines safety and pharmacovigilance
by: Rabia Hussain
Published: (2021-06-01) -
Drug Safety Crises Management in Pharmacovigilance
by: Gloria Shalviri, et al.
Published: (2018-05-01) -
Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01) -
Pattern and quality of scientific communications on drug safety produced by a regional pharmacovigilance center in Nepal
by: Palaian S, et al.
Published: (2010-09-01) -
Pharmacovigilance and assessment of drug safety reports during COVID 19
by: Mira K Desai
Published: (2020-01-01)